Moderate

Pre-eclampsia prevention — aspirin prophylaxis & surveillance

PET prevention · Obstetric
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Low-dose aspirin markedly reduces the risk of pre-eclampsia in at-risk women when started before 16 weeks. Risk stratification at booking plus structured BP and proteinuria surveillance underpins prevention.

Red flags

  • BP 160/110 or higher
  • New significant proteinuria
  • Severe headache, visual disturbance or epigastric pain
  • Rapidly progressive oedema
  • Reduced fetal movements or growth restriction

Assessment

Differential diagnosis

  • Chronic hypertension
  • Gestational hypertension
  • White-coat hypertension
  • Secondary hypertension
  • Pre-existing renal disease

Investigations

  • Baseline booking BP and urine protein:creatinine ratio
  • FBC, renal and liver function, urate at baseline if high risk
  • Uterine artery Doppler where available in high-risk women
  • Serial BP and urinalysis at each antenatal contact
  • PlGF-based testing (sFlt-1/PlGF ratio) to help rule out pre-eclampsia when suspected
  • Serial growth scans in high-risk women

Management

  • Assess at booking for high-risk factors (previous pre-eclampsia, chronic hypertension, CKD, diabetes, autoimmune disease) and moderate-risk factors (first pregnancy, age over 40, BMI over 35, family history, multiple pregnancy, interval over 10 years)
  • Start aspirin for any one high-risk or any two moderate-risk factors
  • Commence aspirin from 12 weeks, ideally before 16 weeks, and continue until 36 weeks
  • Advise adequate calcium intake and consider supplementation in low-intake populations
  • Educate on warning symptoms and provide written safety-netting
  • Arrange BP and urinalysis at every visit with increased frequency in high-risk women
  • Use PlGF-based testing to support diagnosis when pre-eclampsia is suspected between 20 and 37 weeks
  • Escalate to obstetric assessment promptly if BP rises or proteinuria develops

Drugs & doses

Aspirin 150 mg PO once daily at night from 12 weeks to 36 weeks (75-162 mg acceptable where 150 mg unavailable)
Calcium carbonate 1-1.5 g PO once daily if dietary calcium is low
Labetalol 200 mg PO twice daily if hypertension develops (first-line)

Disposition

Community-based surveillance with aspirin for at-risk women; refer to obstetric-led antenatal clinic and arrange day-unit review promptly if hypertension or proteinuria emerges.

Complications & pitfalls

  • Early-onset pre-eclampsia
  • Fetal growth restriction
  • Placental abruption
  • Progression to eclampsia or HELLP
  • Iatrogenic preterm birth

Exam pearls

  • Night-time dosing of aspirin may improve efficacy
  • Aspirin begun after 16 weeks has reduced benefit so identify risk early
  • A normal sFlt-1/PlGF ratio has a high negative predictive value over the next week
  • Continue aspirin despite minor bruising; it is safe for neuraxial anaesthesia

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.